全国服务咨询热线：
18438616290
18438616290
产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 1195768-06-9 |
|---|---|---|---|
| 分子式 | C24H24F3N5O5S3 | 纯度 | ＞98% |
| 分子量 | 615.67 | 货号 | abs810452 |
| 规格 | 5mg | 供货周期 | 现货 |
| 主要用途 | is an orally bioavailable inhibitor of B | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
Dabrafenib Mesylate 1195768-06-9
| 产品描述 | |
| 描述 | Dabrafenib is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. |
| 纯度 | >98% |
| 储存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 别名 | Dabrafenib Mesylate (GSK 2118436B);GSK-2118436 Mesylate; GSK2118436 Mesylate; GSK 2118436 Mesylate |
| 外观 | Powder |
| 可溶性/溶解性 | DMSO: ≥ 36 mg/mL |
| 生物活性 | |
| 靶点 | B-Raf (V600E) ,B-Raf ,C-Raf |
| In vitro(体外研究) | Dabrafenib displayed compelling inhibitory activity in enzyme and cellular mechanistic assays, and in cell proliferation assays in B-RafV600E-driven melanoma lines, SKMEL28 and A375P F11 (IC50 = 3 and 8 nM, respectively), and colorectal carcinoma line Colo205 (IC50 = 7 nM). Dabrafenib has a minimal effect in vitro on cells with wild-type B-Raf (HFF IC50 = 3.0 μM) and in tumor cells not harboring the activating B-RafV600E mutation. It is highly selective, exhibiting >500-fold selectivity for B-RafV600E compared to most kinases screened. Significant activity (. Cellular inhibition of BRAFV600E kinase activity by dabrafenib resulted in decreased MEK and ERK phosphorylation and inhibition of cell proliferation through an initial G1 cell cycle arrest, followed by cell death. |
| In vivo(体内研究) | In a BRAFV600E-containing xenograft model of human melanoma, orally administered dabrafenib inhibited ERK activation, downregulated Ki67, and upregulated p27, leading to tumor growth inhibition. Dabrafenib is orally bioavailable, doesn’t significantly accumulate after multiple dosing, and causes a reduction of pERK that is sustained for up to 18 h post-dosing after 7 and 14 days of dosing. |
| 研究领域 | |
| 研究领域 | CancerTumor biomarkers Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询
地址：上海市浦东新区新浩路58号申江科创园18栋
邮箱：lanwu@univ-bio.com
传真：